Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Spero Therapeutics Inc. (SPRO)

11.37   -0.03 (-0.26%) 05-24 16:00
Open: 11.46 Pre. Close: 11.4
High: 11.78 Low: 11.09
Volume: 23,129 Market Cap: 199M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.792 - 11.856 11.856 - 11.91
Low: 10.939 - 11.017 11.017 - 11.081
Close: 11.251 - 11.372 11.372 - 11.472

Technical analysis

as of: 2019-05-24 4:29:49 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 15.66     One year: 18.29
Support: Support1: 5.84    Support2: 1.16
Resistance: Resistance1: 13.41    Resistance2: 15.66
Pivot: 11.16
Moving Average: MA(5): 11.75     MA(20): 11.18
MA(100): 11.16     MA(250): 10.63
MACD: MACD(12,26): -0.30     Signal(9): -0.40
Stochastic oscillator: %K(14,3): 85.99     %D(3): 87.25
RSI: RSI(14): 49.83
52-week: High: 18.23  Low: 1.16  Change(%): 9.2
Average Vol(K): 3-Month: 7971  10-Days: 5861

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
SPRO has closed below upper band by 48.1%. Bollinger Bands are 261.7% wider than normal. The large width of the bands suggest high volatility as compared to SPRO's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Fri, 10 May 2019 02:04:53 Z
Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue Estimates

Thu, 02 May 2019 17:22:11 Z
Analysts Estimate Spero Therapeutics, Inc. (SPRO) to Report a Decline in Earnings: What to Look Out for

Mon, 01 Apr 2019 22:19:36 Z
Spero Gets Fast Track Designation for SPR994, Shares Improve

Fri, 15 Mar 2019 14:20:57 Z
Will Spero Therapeutics Continue to Surge Higher?

Fri, 09 Nov 2018 03:55:27 Z
Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 17.52
Shares Float (M) 17.42
% Held by Insiders
% Held by Institutions 57.00
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -2.630
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS -5.767
Book Value (p.s.) 1.860
PEG Ratio -0.15
Profit Margin
Operating Margin -357.86
Return on Assets (ttm) -36.4
Return on Equity (ttm) -39.9
Qtrly Rev. Growth 569.4
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -38.59
Levered Free Cash Flow (M) -27.32

Stock Valuations

P/E -4.32
P/E Growth Ratio
P/BV 6.11
P/S 316194272.00
P/CF -5.16

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.